Connect with us

Industry News

THC Therapeutics Announces The US Patent office is granting a patent for their Cannabis Dryer

Avatar

Published

on

default_cannabis_industry_cannamaps

The dHydronator® is a Sanitizing Cannabis/Herb Sanitizing Dryer
LAS VEGAS, Nov. 08, 2018 (GLOBE NEWSWIRE) — THC Therapeutics Inc  (OTC: MBLC) is a forward-thinking publicly traded Health and Wellness company in the cannabis industry that has “Better Health through the Science of Nature” as their guiding statement. Today announced that they will focus their operations on the Cannabis industry and their soon-to-be issued patent for “The dHydronator®.”THC Therapeutics developed a sanitizing herb dryer, The dHydronator®, with multiple design, function, and usages. The Company anticipates that the patent will be issued within the next two months. This innovative, laboratory-proven product is specifically designed for drying and sanitizing freshly harvested Cannabis, herbs, teas, etc. The dHydronator® can reduce moisture content of Cannabis to 10% in only 10-14 hours. Traditional Cannabis drying times take up to two weeks.Another one of the major aspects of The dHydronator® is that it has been proven to destroy harmful surface contaminants & pathogens. With our built-in, SanitiZen® technology, we are able to reduce the microbial load from failing in cannabis and bring the contaminants down to passing levels.The dHydronator® has been tested by two independent laboratories  the last being DigiPath https://digipath.com/ (OTCQB: DIGP), testing covered over 6 strains and 9 independent tests to confirm the findings. The strains tested were Lucy Diamond, Cotton Candy, Blue Dream, Kings Cut, Pot of Gold and Diablo. Our SanitiZen technology brought the failing TAC (total aerobic count) from over 300,000 down to 78,000. The optimal drying time was determined to be 10-14 hours, but may vary by region and ambient humidity. By far the most surprising data from the testing was the potency of the cannabis after exposure to the dHydronator. Over the 9 tests and 6 strains, there was a 4% average increase of THC-A*.*See complete results at https://THCtherapeutics.com/index.php/dhydronator/These results exceeded our expectations and were surprising even to us. We cannot be be more pleased with what the dHydronator® can do.
In late July of 2018, the Company’s patent attorney received notice from the United States Patent and Trademark Office (the “USPTO”) that the USPTO would be allowing all 20 of our patent claims for The dHydronator®. In light of this development, and after analyzing the current regulatory environment regarding companies focused on investing in cryptographic tokens and other digital assets, the Company then determined that it would refocus its efforts on developing the soon-to-be patented dHydronator®, and the Company changed its name to “THC Therapeutics, Inc.”The Company also filed a Form 10 Registration Statement with the U.S. Securities and Exchange Commission on October 22, 2018. The Company intends to be a fully reporting issuer on December 21, 2018, which is 60 days from the date of the Form 10 filing. See- https://www.sec.gov/Archives/edgar/data/1404935/000147793218004955/mblc_1012ga.htmIn light of the Company’s name change and new business focus, the Company will be filing a notification with FINRA for a ticker symbol and name changeBrandon Romanek, our Founder and CEO, stated, “I could not be more elated that the US patent office has accepted ALL 20 of our claims for The dHydronator®. We filed for patent protection well over 2 years ago, but we did not expect to receive such broad protection on our intellectual property. Many experts in the cannabis industry liked our technology; however, they expressed serious doubts that we would receive any type of patent protection— much less the broad protection afforded by all 20 of our claims.”Romanek further commented, “Today THC Therapeutics is a much stronger company than we were just 8 months ago. Then, we only had a pending patent, with few other assets. Since then we have invested in Blockchain-related companies. We issued restricted shares to those companies and have the right to receive equity and/or tokens from those companies. https://www.impactppa.com and https://www.robotcache.com/ intend to have a token creation event by the first quarter of next year, and the Company expects to receive tokens in connection with them. I am a firm believer in Blockchain and Crypto, and plan to stay on top of regulatory and market changes.  I am pleased with the progress we have made since we went public in January of 2017 via reverse merger. We have taken solid steps to turn our vision into reality.”The Company intends to provide information regarding further updates on the patent status and its plans moving forward in future press releases.About THC TherapeuticsTHC Therapeutics, Inc. (OTC: MBLC) is focused on developing The dHydronator®, a sanitizing herb dryer. The main function of The dHydronator® is to greatly accelerate the drying time of a herb while sanitizing it. The dHydronator® can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis, and it will reduce the drying time for cannabis from 10-14 days to less than 14 hours. The Company plans to also focus some of its operations on participation in cannabis testing lab facilities and developing personal wellness centers, as well as investigating other potentially disruptive technologies The Company is seeking partnerships, mergers and acquisitions in the Cannabis, Health and Wellness industries in the United States & Canada. For more information, visit THCtherapeutics.com.Follow Brandon Romanek on Twitter:
Twitter @BrandonRomanek
Follow THC Therapeutics on Facebook
https://www.facebook.com/THCtherapetuics
About Digipath, Inc.Digipath, Inc. supports the cannabis industry’s best practices for reliable testing, cannabis education and training, and brings unbiased cannabis news coverage to the cannabis industry. Digipath Labs provides pharmaceutical-grade analysis and testing to the cannabis industry to ensure producers, consumers, and patients know exactly what is in the cannabis they ingest and to help maximize the quality of its client’s products through analysis, research, development, and standardization.Forward-Looking Statements DisclosureThis press release may contain “forward-looking statements” within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company’s expected future business and financial performance, and often contain words such as “anticipates,” “beliefs,” “estimates,” “expects,” “intends,” ” plans,” “seeks,” “will,” and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.PR & Media Contact:
(702) 602-8422
info@THCtherapeutics.com

Original story can be found at: http://globenewswire.com/news-release/2018/11/08/1647863/0/en/THC-Therapeutics-Announces-The-US-Patent-office-is-granting-a-patent-for-their-Cannabis-Dryer.html?f=22&fvtc=5&fvtv=41223728

Continue Reading

Industry News

CV Sciences, Inc. Expands Operations with New Production and Warehousing Facility to Support Worldwide Growth Opportunities

Avatar

Published

on

default_cannabis_industry_cannamaps

Facility Expansion Increases Hemp CBD Oil Production and Warehousing/Fulfillment Capacity by More Than 500 Percent
SAN DIEGO, July 16, 2019 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products through its industry-dominating brand, PlusCBD™ Oil, today announced the expansion of its operations with a new production and warehouse facility.The 45,500 square foot facility will expand the Company’s capacity for hemp CBD oil production, warehousing and fulfillment by more than 500 percent to meet growing retailer and consumer demand for PlusCBD™ Oil products.  The facility, located in San Diego, is expected to be operational in the fourth quarter of 2019 and will support CV Sciences’ U.S. and international expansion opportunities.“Our recently announced U.S. hemp sourcing initiative combined with this facility and capacity expansion positions CV Sciences for continued rapid domestic growth, while ensuring we are well-positioned to capitalize on the international opportunities we are currently exploring,” said Joseph Dowling, Chief Executive Officer.  “The distribution of PlusCBD™ Oil products into national retailers in the Food, Drug and Mass (FDM) channel is growing significantly, yet we are still in the early stages of growth. Despite more than doubling the number of stores carrying our industry leading products to 4,591 stores in the first six months of this year, we see a significant runway for additional growth, including increasing our domestic and international store count, as well as broadening product SKUs with our retail partners.”On July 10, 2019, CV Sciences announced the commencement of its domestic hemp sourcing initiative, including a commitment to more than 500 acres of U.S.-based hemp production for 2019.  This new supply of U.S. produced hemp-based CBD will be extracted through CV Sciences’ domestic supply chain partners and refined at the Company’s San Diego production facilities, broadening the Company’s global supply chain and raw material supply while reducing transportation and logistics costs.Dowling continued, “CV Sciences is the first hemp CBD company to achieve self-affirmed Generally Recognized as Safe (GRAS) status in accordance with stringent U.S. Food and Drug Administration safety guidelines.  Our relentless commitment to regulatory leadership as well as product safety, quality and efficacy through scientific evidence has established confidence and trust with retailers and consumers.  Expanding our GRAS raw material supply capability builds on our strong foundation to make PlusCBD™ Oil products available to more consumers around the globe.”About CV Sciences, Inc.CV Sciences, Inc. (OTCQB:CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a drug development division focused on developing and commercializing novel therapeutics utilizing CBD. The Company’s PlusCBD™ Oil is the top-selling brand of hemp-based CBD on the market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences, Inc. has primary offices and facilities in San Diego, California.  Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.CONTACT INFORMATION:Investor Contact:
ICR
Scott Van Winkle
617-956-6736
scott.vanwinkle@icrinc.com
Media Contact:
ICR
Cory Ziskind
646-277-1232
cory.ziskind@icrinc.com

Original story can be found at: http://www.globenewswire.com/news-release/2019/07/16/1883333/0/en/CV-Sciences-Inc-Expands-Operations-with-New-Production-and-Warehousing-Facility-to-Support-Worldwide-Growth-Opportunities.html?f=22&fvtc=5&fvtv=41223728

Continue Reading

Industry News

MustGrow Biologics Corp. Featured in Exclusive NetworkNewsWire Broadcast

Avatar

Published

on

default_cannabis_industry_cannamaps

NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) — via NetworkNewsAudio – MustGrow Biologics Corp. (CSE: MGRO), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and bio-fertilizers, today announces the broadcast of its exclusive audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community.
The interview can be heard at http://nnw.fm/WDud1.MustGrow president and CEO Corey Giasson joins NNW host Stuart Smith in a discussion about the company’s novel, proprietary technology that utilizes organic components refined from the mustard seed to provide high-quality organic solutions for growers facing soil borne diseases and pests such as nematodes in their greenhouses and fields.“We’re an agriculture biologics company that has an innovative technology which uses the mustard seed,” Giasson explains. “We take the mustard seed and extract the natural compounds from that mustard seed, concentrate them, and with them they can be used as a natural bio-fumigate or biopesticide in the food and vegetable industry as well as potentially in the cannabis industry.”Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients.MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The company’s initial product was produced in granular form and sold to growers in the fruit and vegetable space, specifically to strawberry growers, Giasson says.“Our second-generation technology is in liquid form and is more concentrated,” he adds. “We are looking forward to getting the regulatory approval to start selling that into the market.”MustGrow’s potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Giasson notes that “a lot of the funguses that affect the strawberry plant also affect the cannabis plant.”The company’s management team and advisory board is stacked with experts in the agriculture biotech industry and vertical biologics, along with renowned experts in the cannabis space such as Tom Flow, founder of The Flowr Corporation. MustGrow recently announced closing of a non-brokered $1.2 million private placement with those funds already dedicated to developing and commercializing its patented technology, finalizing formulations and conducting field tests on cannabis crops.MustGrow’s biopesticide has U.S. EPA (Environmental Protection Agency) and Canadian PMRA (Pest Management Regulatory Agency) labels as an approved organic solution and is seeking approval to add cannabis as an accepted use.About MustGrowMustGrow is an agricultural biotech company focused on developing and commercializing a portfolio of patented natural bio-pesticides and bio-fertilizers, including its patented signature mustard-derived biologics. Targeting the fruit and vegetable and the cannabis industries, MustGrow has designed a U.S. EPA and Canadian PMRA approved organic solution that uses the mustard seed’s natural defense mechanisms to protect plants from pests and diseases.To learn more, please contact the Company at 1 (306) 717-1128 or visit: www.mustgrow.caAbout NetworkNewsAudioNetworkNewsAudio (NNA) , a NetworkNewsWire (NNW) Solution, allows you to sit back and listen to market updates, CEO interviews and a Company AudioPressRelease (APR). These audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio (NNA) can assist your company by cutting through the overload of information in today’s market, NNA brings its clients unparalleled visibility, recognition and brand awareness. NetworkNewsWire (NNW) is where news, content and information converge. NetworkNewsWire (NNW) is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW has the unparalleled ability to reach a wide audience of investors, consumers, journalists and the general public with an ever-growing distribution network of more than 5,000 key syndication outlets across the nation.For more information, visit: www.NetworkNewsAudio.comPlease see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer.Forward-Looking StatementsThis release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.Corporate Communications:NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com 
212.418.1217 Office 
Editor@NetworkWire.com 

Original story can be found at: http://www.globenewswire.com/news-release/2019/07/16/1883316/0/en/MustGrow-Biologics-Corp-Featured-in-Exclusive-NetworkNewsWire-Broadcast.html?f=22&fvtc=5&fvtv=41223728

Continue Reading

Industry News

Greenlane Granted Second Patent for Pollen Gear™ Child-Resistant SnapTech® Bags

Avatar

Published

on

default_cannabis_industry_cannamaps

BOCA RATON, Fla., July 16, 2019 (GLOBE NEWSWIRE) — Greenlane Holdings, Inc. (Nasdaq: GNLN) (“Greenlane”), a leading distributor of premium vaporization products and consumption accessories, today announced that the U.S. Patent Office has granted the Company its second patent for Pollen Gear’s child-resistant SnapTech® Bags used by leading cannabis brands such as MedMen, Organigram and Farma.
Pollen Gear™, the leading producer of premium, customizable and patented child-resistant packaging solutions, is a wholly-owned subsidiary of Greenlane following its January 2019 acquisition.  Prior to the acquisition, Greenlane was the exclusive global distributor of Pollen Gear products and the companies have a proven track record of bringing industry leading products that promote product safety and responsible consumption to legal cannabis markets.United States Patent Numbers D843,225 and D807,197 cover Pollen Gear’s snap-locking mechanism, which provides cannabis brands with ASTM child-resistant solutions to the ever changing packaging compliance landscape.  This new patent adds to Greenlane’s existing global portfolio of more than 100 patents and patent applications directed across all Pollen Gear container technology, which includes over 30 patents and patent applications for the trendsetting Hi-Line™ jar, a now iconic design that is virtually synonymous with premium cannabis.“The integration of Pollen Gear’s award-winning team of designers and engineers into our business has accelerated our product development and innovation, allowing Greenlane to bring our customers a higher quality of service and a wider array of packaging solutions,” said Aaron LoCascio, Chairman and Chief Executive Officer of Greenlane.  “With this new patent for Pollen Gear’s SnapTech Bags, our customers can be assured that they are using packaging that has been tested at 100% child-resistant effectiveness, ensuring product safety and responsible consumption, while preserving the quality of their cannabis products and brands. We look forward to providing further updates on our packaging innovations as we bring more solutions to market and capitalize on this growth opportunity.”Pollen Gear is a leading supplier of premium child-resistant packaging to the cannabis industry and is credited with creating the category. Founded in 2015, Pollen Gear creates unique packaging solutions, with a focus on recyclable and sustainable materials. Pollen Gear was recognized as a Top 100 Cannabis Company in 2018 by Entrepreneur Magazine.About Greenlane Holdings, Inc.Greenlane (NASDAQ: GNLN) is a leading distributor of premium vaporization products and consumption accessories in the United States and has a growing presence in Canada. Greenlane’s customers include over 7,000 independent smoke shops and regional retail chain stores, which collectively operate approximately 11,000 retail locations, and hundreds of licensed cannabis cultivators, processors and dispensaries. Greenlane also owns and operates one of the most visited North American direct-to-consumer e-commerce websites in the vaporization products and consumption accessories industry, Vapor.com, a unique e-commerce platform which offers convenient, flexible shopping solutions directly to consumers. Through Greenlane’s expansive North American distribution network and e-commerce presence, Greenlane offers a comprehensive selection of premium vaporizers and parts, cleaning products, grinders and storage containers, pipes, rolling papers and customized lines of premium specialty packaging. Following the passage of The Agriculture Improvement Act of 2018 (“The Farm Bill”) in February 2019, Greenlane commenced distribution of premium products containing hemp-derived cannabidiol in those states in which the distribution and sale of such products are authorized by, and can be affected in compliance with, applicable state laws and regulations.Media Contact:
Cory Ziskind
ICR
646-277-1232
greenlane@icrinc.com
Investor Contact:
Scott Van Winkle
ICR
617-956-6736
scott.vanwinkle@icrinc.com

Original story can be found at: http://www.globenewswire.com/news-release/2019/07/16/1883274/0/en/Greenlane-Granted-Second-Patent-for-Pollen-Gear-Child-Resistant-SnapTech-Bags.html?f=22&fvtc=5&fvtv=41223728

Continue Reading

Trending